Ganglioside interactome toolkit
Ganglioside interactome toolkit
批准号:
10163818
负责人:
RONALD L SCHNAAR
金额:
$49.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2023-06-30
关键词:
AddressAlkynesAzidesBindingBinding ProteinsBiologyBiomedical ResearchBiotinCarrier ProteinsCell CommunicationCell Culture TechniquesCell membraneCell physiologyCell surfaceCellsCeramidesChargeChemicalsChemistryDiabetes MellitusDiazomethaneDiseaseEndocytosisGangliosidesGlycosphingolipidsGoalsHealthHumanHydrogen BondingIntegral Membrane ProteinIntellectual functioning disabilityIntracellular MembranesLaboratoriesLaboratory ResearchLinkLipidsMalignant NeoplasmsMediatingMethanolMethodsMinorityMolecularMyelin Associated GlycoproteinNerve DegenerationNervous system structureNeurodegenerative DisordersOutcomePlayPolysaccharidesProductionProteinsProteomeProteomicsProtocols documentationReagentResearch PersonnelRoleSialic AcidsSignal PathwaySignal TransductionSiteSpecificityStructureSurfaceSystemTechnologyTissuesValidationexperimental studyextracellularfluorophorefunctional grouphuman diseaseinterestmetabolomicstool
中文摘要
神经节苷脂,唾液酸化鞘糖脂,存在于所有脊椎动物细胞和组织中,
在影响人类疾病(包括糖尿病、癌症、神经系统疾病)的多种分子信号通路中发挥作用,
变性蛋白质病、智力残疾和许多其他疾病。主要的神经节苷脂结构是
定义明确、有限且在脊椎动物物种间共享。它们的聚糖独立调节细胞信号
一种蛋白质载体。大多数神经节苷脂存在于细胞表面,其神经酰胺脂质嵌入细胞膜中。
质膜和它们的聚糖向外延伸。它们以两种方式调节细胞生理学,顺式和
译作为顺式调节剂,它们通过聚糖结合到相同细胞中的跨膜蛋白而横向缔合。
细胞膜调节其功能。作为反式识别分子,它们与蛋白质结合,
细胞外环境或并置细胞上,介导细胞-细胞相互作用。顺式和反式相互作用都是
对神经节苷脂聚糖结构具有特异性,对人类健康至关重要。
大多数神经节苷脂的功能和神经节苷脂-蛋白质相互作用仍然知之甚少,因为缺乏
广泛使用、适应性强和经过验证的工具以及优化的使用方法。这是我们的目标
利用化学生物学技术解决这一需要的项目,以合成一套确定的主要
神经节苷脂携带最小破坏性的双功能光反应和炔(点击化学)标签。
将生成优化和验证的方案,以将双功能标记的神经节苷脂递送到外部细胞。
细胞质膜的小叶,大多数神经节苷脂居住和发挥功能。我们的目标是
合成神经节苷脂探针工具包,验证探针的适当细胞递送,验证它们用于
鉴定聚糖特异性神经节苷脂结合蛋白,并将试剂和方案转移到其他
生物医学研究实验室在这个项目的期限内。可交付成果、神经节苷脂探针和
经验证的方法,将广泛分发给生物医学研究人员,以发现身份,
与多种人类细胞相关的神经节苷脂结合蛋白的特异性、分布和功能,
组织和疾病。
英文摘要
Gangliosides, sialylated glycosphingolipids found on all vertebrate cells and tissues, play well-established
roles in diverse molecular signaling pathways that impact human diseases including diabetes, cancer, neuro-
degenerative proteinopathies, intellectual disability, and many others. The major ganglioside structures are
well-defined, finite, and shared across vertebrate species. Their glycans regulate cell signaling independent
of a protein carrier. Most gangliosides reside on the cell surface with their ceramide lipids embedded in the
plasma membrane and their glycans extending outward. They regulate cell physiology in two modes, cis and
trans. As cis regulators, they associate laterally via glycan binding to transmembrane proteins in the same
cell membrane to regulate their function. As trans recognition molecules they engage proteins in the
extracellular milieu or on apposing cells, mediating cell-cell interactions. Both cis and trans interactions are
specific for ganglioside glycan structures and essential for human health.
Most ganglioside functions and ganglioside-protein interactions remain poorly understood due to lack of
broadly accessible, adaptable and validated tools and optimized methods for their use. It is the goal of this
project to address this need using chemical biology technologies to synthesize a defined set of major
gangliosides carrying minimally disruptive bifunctional photoreactive and alkyne (click chemistry) tags.
Optimized and validated protocols will be generated to deliver bifunctionally tagged gangliosides to the outer
leaflet of the plasma membrane of cells, where most gangliosides reside and function. Our goal is to
synthesize the ganglioside probe toolkit, validate appropriate cell delivery of the probes, validate their use to
identify glycan-specific ganglioside binding proteins, and transfer the reagents and protocols to other
biomedical research laboratories within the term of this project. The deliverables, ganglioside probes and
validated methods for their use, will be distributed broadly to biomedical researchers to discover the identities,
specificities, distributions and functions of ganglioside binding proteins relevant to a variety of human cells,
tissues, and diseases.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1111/jnc.15446
发表时间:
2021-08
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[Mlinac-Jerkovic K, Ilic K, Zjalić M, Mandić D, Debeljak Ž, Balog M, Damjanović V, Maček Hrvat N, Habek N, Kalanj-Bognar S, Schnaar RL, Heffer M]
通讯作者:
Heffer M
DOI:
10.3390/ijms222413590
发表时间:
2021-12-18
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Ilic K, Lin X, Malci A, Stojanović M, Puljko B, Rožman M, Vukelić Ž, Heffer M, Montag D, Schnaar RL, Kalanj-Bognar S, Herrera-Molina R, Mlinac-Jerkovic K]
通讯作者:
Mlinac-Jerkovic K
Ganglioside interactome toolkit
-
批准号:9813609
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2019
-
负责人:RONALD L SCHNAAR
-
依托单位:
Human siglec ligands control mast cell and eosinophil mediated inflammation
-
批准号:10331727
-
项目类别:
-
资助金额:$46.38万
-
财政年份:2018
-
负责人:RONALD L SCHNAAR
-
依托单位:
Human siglec ligands control mast cell and eosinophil mediated inflammation
-
批准号:10097998
-
项目类别:
-
资助金额:$51.0万
-
财政年份:2018
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8289349
-
项目类别:
-
资助金额:$220.75万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:9277536
-
项目类别:
-
资助金额:$223.62万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8072323
-
项目类别:
-
资助金额:$231.17万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8722274
-
项目类别:
-
资助金额:$4.64万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8477244
-
项目类别:
-
资助金额:$205.87万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Glycobiology of Inflammatory Lung Diseases
-
批准号:8669096
-
项目类别:
-
资助金额:$214.16万
-
财政年份:2011
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:8018568
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:7767664
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:7873111
-
项目类别:
-
资助金额:$9.53万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:7577517
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:8214620
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Targeting Endogenous Inhibitors to Enhance Spinal Axon Regeneration After Injury
-
批准号:7461889
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2008
-
负责人:RONALD L SCHNAAR
-
依托单位:
Enhancing axon regeneration by multi-inhibitor blocking
-
批准号:6895160
-
项目类别:
-
资助金额:$22.69万
-
财政年份:2004
-
负责人:RONALD L SCHNAAR
-
依托单位:
Enhancing axon regeneration by multi-inhibitor blocking
-
批准号:6770878
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2004
-
负责人:RONALD L SCHNAAR
-
依托单位:
Pharmacology Training Grant
-
批准号:6894128
-
项目类别:
-
资助金额:$32.5万
-
财政年份:2000
-
负责人:RONALD L SCHNAAR
-
依托单位:
PHARMACOLOGY TRAINING GRANT
-
批准号:6628729
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2000
-
负责人:RONALD L SCHNAAR
-
依托单位:
PHARMACOLOGY TRAINING GRANT
-
批准号:6498520
-
项目类别:
-
资助金额:$27.7万
-
财政年份:2000
-
负责人:RONALD L SCHNAAR
-
依托单位:
海外基金